SIRS-Lab appoints Ed Currie as Executive Vice-President, Corporate Development
SIRS-Lab announced the appointment of Dr. Edward Currie as Executive Vice-President, Corporate Development. In this newly created role, Ed will drive partnering, licensing, companion diagnostics, and corporate business development activities at SIRS-Lab.

Ed Currie, SIRS-Lab Executive Vice-President, Corporate Development.
SIRS-Lab
Ed Currie, a physician specialized in clinical microbiology and infectious disease, brings 20 years of diagnostic and pharmaceutical industry experience at Eli Lilly, F. Hoffmann-La Roche, IBM, and, most recently, as COO of Kuros BioSurgery. At Roche, as Global Head of Disease Management, Ed created the company’s first integrated Pharma-Diagnostic approach for targeted treatment and personalized medicine.
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.